长春西汀治疗慢性脑供血不足的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Vinpocetine on patients with chronic cerebral insufficiency.Methods Forty-two patients with chronic cerebral insufficiency who were treated in our hospital from May 2016 to May 2019 were randomly divided into the control group and the observation group by lottery,each group had 21 patients,on the bases of conventional treatment,the control group accepted Ginkgo Damamo Injection,and the observation group accepted Vnpocetine,and the clinical effectiveness,blood flow rate and adverse reactions before and after treatment were compared between the two groups. Results The total clinical effective rate of the observation group was higher than that of the control group,and the difference was statistically significant (P<0.05).There was no significant difference in blood flow velocity of patients between the two groups before treatment,the difference was not statistically significant (P>0.05).The blood flow velocity after treatment was faster than that of the control group,the difference was statistically significant (P<0.05).The total incidence of adverse reactions was lower than that of the control group,the difference was statistically significant (P<0.05).Conclusion Vinpocetine can improve the clinical efficiency of patients with chronic cerebral insufficiency,and the adverse drug reactions are small,which is worth promoting.

Key words： Vinpocetine Chronic cerebral insufficiency Blood flow velocity Safety

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Li-min

Cite this article:

ZHANG Li-min. Clinical effect of Vinpocetine in the treatment of chronic cerebral insufficiency[J]. 中国当代医药, 2020, 27(21): 76-78.

URL:

https://dangdaiyiyao.com/EN/ OR https://dangdaiyiyao.com/EN/Y2020/V27/I21/76

[1]	梅芳.长春西汀治疗慢性脑供血不足疗效观察[J].中国药业，2018，27（1）：58.
[2]	刘国荣，王大力，张文丽，等.逐瘀通脉胶囊联合长春西汀治疗慢性脑供血不足的临床研究 [J].天津中医药，2012，29（1）：22-25.
[3]	Chukanova EI，Mamaeva KI，Chukanova AS.Treatment of chronic cerebral venous insufficiency：A study on an effect of L-lysine aescinat[J].Zh Nevrol Psikhiatr Im S S Korsakova，2016，116（7）：37.
[4]	吕传真，周良辅，洪震，等.实用神经病学[M].4 版.上海：上海科学技术出版社，2014：125-169.
[5]	刘国荣，李旗，田福玲，等.逐瘀通脉联合长春西汀对慢性脑供血不足患者血清hs-CRP、FIB 水平变化的影响[J].中医药学报，2014，42（3）：171-173.
[6]	邓燕.长春西汀治疗慢性脑供血不足的疗效观察[J].中国实用神经疾病杂志，2016，19（14）：20-21.
[7]	魏凯.补中益气汤加味联合长春西汀对气虚下陷型慢性脑供血不足患者血浆H2S、CBS 水平的影响[J].现代中西医结合杂志，2017，26（10）：1059-1061.
[8]	郭迎霞.长春西汀联合低分子肝素钙治疗老年慢性脑供血不足42 例临床分析[J].中国实用神经疾病杂志，2018，21（12）：1354-1357.
[9]	刘国荣，李旗，田福玲，等.逐瘀通脉联合长春西汀对慢性脑供血不足患者血浆H2S、CBS 水平变化的影响[J].天津中医药大学学报，2014，33（2）：75-77.
[10]	陈莹.长春西汀与舒血宁治疗慢性脑供血不足的效果[J].中国民康医学，2019，31（5）：22-24.
[11]	乔娜.长春西汀治疗慢性脑供血不足的临床治疗效果评价[J].医学理论与实践，2017，30（17）：2550-2551.
[12]	胡淑梅，张利焕，张爽.长春西汀治疗慢性脑供血不足临床效果观察[J].北方药学，2017，14（3）：62-63.
[13]	崔艳丽.长春西汀治疗慢性脑供血不足的疗效观察[J].中国处方药，2018，16（8）：80-81.
[14]	郭爱武.长春西汀治疗慢性脑供血不足临床疗效分析[J].系统医学，2018，3（14）：60-61.
[15]	舒孔亮.长春西汀治疗慢性脑供血不足的临床效果及安全性分析[J].按摩与康复医学，2019，10（7）：35-36.
[16]	孙健.长春西汀治疗慢性脑供血不足的临床疗效及安全性[J].中国现代药物应用，2019，13（15）：94-95.